Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus (HTN2DM)
Sponsor: Pamela Youde Nethersole Eastern Hospital
Terminated
Slow recruitment and change in clinical evidence
Other terminated trials from Pamela Youde Nethersole Eastern Hospital
See all terminations from Pamela Youde Nethersole Eastern Hospital
Other Diabetes Mellitus trials with similar outcome
A NA clinical study on Diabetes Mellitus and Hypertension, Resistant, this trial is terminated or withdrawn. The trial is conducted by Pamela Youde Nethersole Eastern Hospital and has accumulated 10 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Dec 2022 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
▶ Show 5 earlier versions
-
Nov 2020 — Dec 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Nov 2018 — Nov 2020 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jul 2018 — Nov 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pamela Youde Nethersole Eastern Hospital
For direct contact, visit the study record on ClinicalTrials.gov .